Our poster collection

Fluency isn’t accuracy: Eliminating AI citation fabrication with Seraj, an agentic biomedical research platform

CHECK IT OUT
Manish Sarkar

MedInsights (FR)

Mechanism-guided feature selection in transcriptomic drug response prediction

CHECK IT OUT
Imane Wifak

Center for AI in Radiation Oncology (CH)

AI-Orchestrated Integration of Structural, Knowledge-Graph, Gene Expression, and Real-World Evidence for Drug Repurposing

CHECK IT OUT
YinHsong Hsu

Repurgenesis (TW)

Beyond Antibiotic Therapy: in silico identification of potential PqsR inhibitors in Pseudomonas aeruginosa

CHECK IT OUT
Mara Custódio

Polytechnic University of Guarda (PT)

Similar Kinases, Distinct Hits: In Silico Repurposing of FDA-Approved Drugs for ALK and ROS1

CHECK IT OUT
Maria Marques

Polytechnic University of Guarda (PT)

RePo_VR: An Immersive Virtual Reality Application for Molecular Docking Visualization in Drug Repurposing

CHECK IT OUT
António Costa

Polytechnic University of Guarda (PT)

Network and Co-Complex Representations Identify Distinct Components of the SynGAP Protein Environment

CHECK IT OUT
Helma Caune

Maastricht University (NL)

GNExT uncovers pharmacological targets from genome-wide association studies through network medicine integration

CHECK IT OUT
Markus List

Technical University of Munich (DE)

Network analysis of Charcot-Marie-Tooth Disease Type 1A prioritises a membrane-homeostasis module and KCNN4 as a candidate drug target

CHECK IT OUT
Julius A. L. Kötting

Maastricht University (NL)

A network medicine framework for mechanism-guided drug combinations in neurological disorders

CHECK IT OUT
Andrea Álvarez

Technical University of Madrid (ES)

Network-Based Prioritisation Identifies More Candidates Beyond a Phenotype-Based Comparator in Alzheimer’s Disease: A NeDRex/ REPO4EU Case Study

CHECK IT OUT
Ute Werner

Uniklinik Aachen (DE)

Network Medicine in Duchenne Muscular Dystrophy Generates a Mechanistic NOS–sGC-Targeted Drug-Repurposing Combination Hypothesis

CHECK IT OUT
Ceren Hangül

Akdeniz University (TR)

Perceived impact and actionability of barriers to drug repurposing: Insights from a multi-stakeholder policy survey

CHECK IT OUT
Kristóf Gyöngyösi

Semmelweis University (HU)

Clinical Trials in Drug Repurposing: An Ethics-by-Design Approach

CHECK IT OUT
Filipa Lopes

University of Porto (PT)

Mapping “Ethics by Design” and “Privacy by Design”: Implications for Precision Medicine and Drug Repurposing

CHECK IT OUT
Maria Strecht Almeida

University of Porto (PT)

Public Health Stakeholder Engagement in Drug Repurposing: Lessons Learned from RePo-SUDOE

CHECK IT OUT
João José Joaquim

Portuguese Society of Public Health (PT)

Developing an R Shiny Health Economic Model Tool to Support Early Decision-Making in Mechanism-Based Drug Repurposing

CHECK IT OUT
Teebah Abu-Zahra

Maastricht UMC+ (NL)

In collaboration with...

Our Bronze Sponsor

JOIN THE SYSTEMS & NETWORK MEDICINE REVOLUTION
IN DRUG REPURPOSING

SUBSCRIBE TO REPO4EU NEWS

Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. This work was also partly supported by the Swiss State Secretariat for Education, Research, and Innovation (SERI) under contract No. 22.00115.